SEARCH

SEARCH BY CITATION

References

  • 1
    The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 97786.
  • 2
    Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M. Predictors of glycemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 2010; 27: 33947.
  • 3
    Cobry E, McFann K, Messer L et al. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther 2010; 12: 1737.
  • 4
    Pankowska E, Szypowska A, Lipka M, Szpotanska M, Blazik M, Groele L. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1C level in children with type 1 diabetes. Pediatr Diabetes 2009; 10: 298303.
  • 5
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009; 32: 137883.
  • 6
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment. Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Trial. Diabetes Care 2010; 33: 1722.
  • 7
    Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care 2010; 33: 10048.
  • 8
    Elleri D, Allen JM, Nodale M et al. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with type 1 diabetes. Diabet Med 2010; 27: 4804.
  • 9
    Hovorka R, Allen JM, Elleri D et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010; 375: 74351.
  • 10
    Bergenstal RM, Tamborlane WV, Ahmann A et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010; 363: 31120.
  • 11
    Chase HP, Beck R, Tamborlane W et al. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005; 28: 11016.
  • 12
    Hirsch IB, Abelseth J, Bode BW et al. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008; 10: 37783.
  • 13
    The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 146476.
  • 14
    Bequette BW. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther 2005; 7: 2847.
  • 15
    Snell-Bergeon JK, West NA, Mayer-Davis EJ et al. Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH case–control study. J Clin Endocrinol Metab 2010; 95: 286876.
  • 16
    Skyler JS, Greenbaum CJ, Lachin JM et al. Type 1 Diabetes TrialNet – an international collaborative clinical trials network. Ann NY Acad Sci 2008; 1150: 1424.
  • 17
    Mastrandera L, Yu J, Behrens T et al. Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized placebo-controlled, double-blind study. Diabetes Care 2009; 32: 12449.
  • 18
    Rother KI, Brown RJ, Morales MM et al. Effect of ingested interferon-α on β-cell function in children with new-onset type 1 diabetes. Diabetes Care 2009; 32: 12505.
  • 19
    Pańkowska E, Błazik M, Dziechciarz P, Szypowska A, Szajewska H. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009; 10: 528.
  • 20
    Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semi automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008; 31: 9349.
  • 21
    The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) Study Group. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther 2008; 10: 31021.
  • 22
    Cryer PE. Panting Lecture: Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994; 43: 137889.
  • 23
    Steffes MW, Sibley S, Jackson M, Thomas W. β-cell function and the development of diabetes-related complications in the Diabetes Control and Complications Trial. Diabetes Care 2003; 26: 8326.